At present, no factors have been identified that fully explain or predict response to RA therapy [24], but pre-treatment differences at baseline between patient groups have been identified, including synovial tissue TNF expression and an increased number of synovial macrophages and T cells in patients who subsequently exhibited clinical improvement after initiation of anti-TNF therapy [25]. The gene discussed is TNF; the disease is rheumatoid arthritis.